ArticleNature communications2018
CRISPR knockout screening identifies combinatorial drug targets in pancreatic cancer and models cellular drug response.
Karol Szlachta et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
50 papers cite it
this papercites it